TH
Thackray Helen M.
Directeur R&D
OtherM
内部人交易记录
高级管理人员尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Thackray Helen M., Directeur R&D. Insider active across 2 companies, notably Biocryst Pharmaceuticals INC. In total, 18 reports have been published. Breakdown: 1 buy · 3 sells. Total volume traded: €359k. Activity tracked since 14 December 2021. The latest transaction was disclosed on 31 March 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Thackray Helen M.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报18 总计
7,525 股@ US$7.509.1% 占其流量Common StockSEC:0001127602-25-011136:0
6,096 股@ US$7.397.6% 占其流量Common StockSEC:0001127602-24-029969:1
125,950 股0Common StockSEC:0001127602-24-029969:0
7,150 股@ US$7.539.0% 占其流量Common StockSEC:0001127602-24-029566:0
30,000 股@ US$5.8628.4% 占其流量Common StockSEC:0001127602-24-015371:0
7,525 股@ US$5.086.2% 占其流量Common StockSEC:0001127602-24-011832:0
3,074 股Common StockSEC:0001104659-24-014717:0
252 股@ US$29.6524.4% 占其流量Common StockSEC:0001415889-24-000372:0
5,580 股@ US$6.055.4% 占其流量Common StockSEC:0001127602-23-030189:0
51,000 股0Common StockSEC:0001127602-23-029839:0
472 股@ US$15.8725.7% 占其流量Common StockSEC:0001415889-23-013759:0
397 股@ US$18.8725.0% 占其流量Common StockSEC:0001415889-23-010819:0
7,000 股@ US$8.299.3% 占其流量Common StockSEC:0001127602-23-012587:0
1,953 股@ US$3.8424.9% 占其流量Common StockSEC:0001415889-23-006063:0
81,000 股0Common StockSEC:0001127602-22-028082:0
3,125 股@ US$10.895.6% 占其流量Common StockSEC:0001127602-22-027887:0
7,600 股@ US$16.2019.4% 占其流量Common StockSEC:0001127602-22-011188:0
44,000 股0Common StockSEC:0001127602-21-031130:0
About Thackray Helen M.
Thackray Helen M. is Director R&D and has reported 18 filings between 2021-12-16 and 2025-04-02. In the recent filings held here, the aggregated amounts are EUR 162559 in buys and EUR 196250 in sells, with the modal transaction nature listed as Attribution.